65. A Novel Aptamer Targeting Agent for Prostate Cancer
Publication
, Conference
Powell Gray, B; Kelly, L; Levy, M; Sullenger, BA
Published in: Molecular Therapy
May 2015
Duke Scholars
Published In
Molecular Therapy
DOI
ISSN
1525-0016
Publication Date
May 2015
Volume
23
Start / End Page
S28 / S29
Publisher
Elsevier BV
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Powell Gray, B., Kelly, L., Levy, M., & Sullenger, B. A. (2015). 65. A Novel Aptamer Targeting Agent for Prostate Cancer. In Molecular Therapy (Vol. 23, pp. S28–S29). Elsevier BV. https://doi.org/10.1016/s1525-0016(16)33670-x
Powell Gray, Bethany, Linsley Kelly, Matthew Levy, and Bruce A. Sullenger. “65. A Novel Aptamer Targeting Agent for Prostate Cancer.” In Molecular Therapy, 23:S28–29. Elsevier BV, 2015. https://doi.org/10.1016/s1525-0016(16)33670-x.
Powell Gray B, Kelly L, Levy M, Sullenger BA. 65. A Novel Aptamer Targeting Agent for Prostate Cancer. In: Molecular Therapy. Elsevier BV; 2015. p. S28–9.
Powell Gray, Bethany, et al. “65. A Novel Aptamer Targeting Agent for Prostate Cancer.” Molecular Therapy, vol. 23, Elsevier BV, 2015, pp. S28–29. Crossref, doi:10.1016/s1525-0016(16)33670-x.
Powell Gray B, Kelly L, Levy M, Sullenger BA. 65. A Novel Aptamer Targeting Agent for Prostate Cancer. Molecular Therapy. Elsevier BV; 2015. p. S28–S29.
Published In
Molecular Therapy
DOI
ISSN
1525-0016
Publication Date
May 2015
Volume
23
Start / End Page
S28 / S29
Publisher
Elsevier BV
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences